Akebia Therapeutics, Inc.
USD0.94
-0.08 (-8.20%)
CEO
John Butler
IPO Date
2014-03-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.01
Prev. Close
$1.02
Day Low
$0.91
Day High
$1.02
52W Low
$0.88
52W High
$4.08
Market Cap
$0.25B
Volume
7.21M
| 0 |
| $0.00 |
| 5 Mar 2026 | Butler John P. | director, officer: CEO and President | P-Purchase | Acquired | 69,270 | $1.25 |
| 4 Feb 2026 | Malabre Richard C | SVP, Chief Accounting Officer | S-Sale | Disposed | 13,382 | $1.39 |
| 4 Feb 2026 | Malabre Richard C | SVP, Chief Accounting Officer | S-Sale | Disposed | 36,142 | $1.39 |
| 4 Feb 2026 | Grund Nicholas | Chief Commercial Officer | S-Sale | Disposed | 31,244 | $1.39 |
| 4 Feb 2026 | Grund Nicholas | Chief Commercial Officer | S-Sale | Disposed | 53,585 | $1.39 |
| 4 Feb 2026 | Burke Steven Keith | SVP, Chief Medical Officer | S-Sale | Disposed | 20,701 | $1.39 |
| 4 Feb 2026 | Burke Steven Keith | SVP, Chief Medical Officer | S-Sale | Disposed | 21,582 | $1.39 |
| 4 Feb 2026 | Burke Steven Keith | SVP, Chief Medical Officer | S-Sale | Disposed | 25,375 | $1.39 |